Patent classifications
C12N2770/24333
Bovine virus vaccines that are liquid stable
The present invention discloses liquid stable bovine vaccines that comprise a live attenuated virus, and a sugar alcohol. The present invention also discloses the manufacture of such vaccines and methods of protecting an animal by administration of such vaccines.
BOVINE VIRAL DIARRHEA VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF
The present disclosure provides an immunogenic composition and methods of treating, preventing, and reducing the duration, incidence, and/or severity of clinical signs or symptoms of BVDV infection. The immunogenic composition includes at least one bovine MHC I-binding peptide. In some forms, the immunogenic composition includes a BPI3Vc vector expressing at least an antigenic CD8+ T cell epitope derived from at least one bovine viral diarrhea virus (BVDV) antigen selected from the group consisting of N.sup.pro, E.sup.rns, E1, E2, NS2-3, NS4A-B, NS5A-B, and any combination thereof.